Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imuneks 10 mg for Cold Prophylaxis in Healthy Subjects
NCT02807220Phase 4Completed
- Sponsor
- Imuneks Farma
- Start
- Feb 2017
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of beta-1,3/1,6-glucan in common cold, sponsored by Imuneks Farma. Started Feb 2017; status: completed.
02
Drugs
beta-1,3/1,6-glucan
03
Conditions
common cold
Beyond the preview
Go deeper on NCT02807220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02807220.